J Korean Ophthalmol Soc > Volume 59(9); 2018 > Article
Journal of the Korean Ophthalmological Society 2018;59(9):887-892.
DOI: https://doi.org/10.3341/jkos.2018.59.9.887    Published online September 15, 2018.
Conjunctival Necrosis following Ahmed Valve Implantation and Subtenon Triamcinolone Injection.
Kee Sup Park, Kyoung Nam Kim, Woo Jin Kim, Sung Bok Lee, Chang sik Kim
Department of Ophthalmology, Chungnam National University Hospital, Chungnam National University College of Medicine, Daejeon, Korea. kkn9901700@hanmail.net
아메드밸브삽입술 및 트리암시놀론 테논낭밑주사 후 발생한 결막 괴사
박기섭⋅김경남⋅김우진⋅이성복⋅김창식
충남대학교 의과대학 충남대학교병원 안과학교실
Correspondence:  Kyoung Nam Kim,
Email: kkn9901700@hanmail.net
Received: 15 March 2018   • Revised: 25 May 2018   • Accepted: 23 August 2018
Abstract
PURPOSE
We report a case of conjunctival necrosis in a glaucoma patient who underwent Ahmed valve implantation and subtenon triamcinolone injection. CASE SUMMARY: subconjunctival injections of mitomycin C in her right eye. Ahmed valve implantation and subtenon triamcinolone injection were performed in the right eye. Four weeks later, conjunctival necrosis was observed. After debridement of necrotic tissue, an additional conjunctival autograft was needed because of recurrence of the conjunctival necrosis. After amniotic membrane transplantation was performed for one more recurrent conjunctival necrosis, conjunctival epithelialization was completed. CONCLUSIONS: Although conjunctival necrosis after periocular injection of triamcinolone is a rare complication, previous multiple usage of antimetabolites such as mitomycin C might be associated with a higher risk of developing conjunctival necrosis. In such cases, aggressive surgical intervention may be helpful in the reconstruction of the conjunctival epithelium.
Key Words: Ahmed valve;Conjunctival necrosis;Glaucoma;Mitomycin C;Triamcinolone


ABOUT
BROWSE ARTICLES
EDITORIAL POLICY
FOR CONTRIBUTORS
Editorial Office
SKY 1004 Building #701
50-1 Jungnim-ro, Jung-gu, Seoul 04508, Korea
Tel: +82-2-583-6520    Fax: +82-2-583-6521    E-mail: kos08@ophthalmology.org                

Copyright © 2024 by Korean Ophthalmological Society.

Developed in M2PI

Close layer
prev next